Tag : cancer biomarkers

Biomarkers

Genialis & CRH Collaborate to develop AI-Driven Patient Classifiers

Business Wire
Partnership provides high-quality and clinically relevant data for modeling and validation of novel biomarkers in UK patients Genialis, the RNA-biomarker company, today announced a new...
Biomarkers

Together selects Sonde Health to Power its Mental Vitals Tool

Business Wire
Commercial partnership enables users of Together’s app to access enhanced mental health tracking through Sonde’s leading voice technology Leading enterprise vocal biomarker company Sonde Health has partnered...
Biomarkers

Rockley Photonics advances Non-Invasive Blood Glucose Monitoring

Business Wire
Rockley has made rapid progress towards noninvasive optical measurement of glucose through benchtop and human studies. Measurement of glucose in simulated skin samples with Rockley’s...
Biomarkers

Genialis announced the addition of several new team members

Business Wire
Class of new hires bring diverse expertise across numerous functions critical to predicting patient response to cancer treatment options Genialis, the RNA-biomarker company, today announced...
Biomarkers

Mainz Biomed strategically Partners with Ärztliches Labor Dr. Buhlmann

GlobeNewswire
Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today a strategic partnership...
Biomarkers

BioAI appoints Dr. J. Carl Barrett to the Scientific Advisory Board

PR Newswire
Translational oncology expert joins BioAI as latest addition to growing scientific advisory board BioAI Health, a leader in AI-powered precision medicine, today announced the appointment of...
Biomarkers

William P. Donnelly appointed to Quanterix’s Board of Directors

Business Wire
Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today announced that it appointed William (Bill) P. Donnelly...
Biomarkers

Kernel launches Cognitive Decline Study Using Flow2 Neuroimaging Technology

Business Wire
Kernel, a leader in non-invasive neuroimaging technology, is excited to announce the commencement of an observational study focused on characterizing early cognitive decline. The first patients in...